SCHEMBL8200480

SCHEMBL8200480

COc1ccccc1-c1cc(-c2ccccc2OC)c2oc(-c3ccccc3C3=NCCN3)cc2c1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ NISCH Q9Y2I1 11/20 0.44
▸ MAOB P27338 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ ADRA2A P08913 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ADRA2B P18089 1/20 0.41
▸ ADRA2C P18825 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ PDCD1LG2 Q9BQ51 3/20 0.38
▸ CD274 Q9NZQ7 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8201933 0.87 NISCH (0.46) NISCHMAOBKDM4EALDH1A1CYP1A2
SCHEMBL8188068 0.84 NISCH (0.50) NISCHMAOBKDM4EALDH1A1CYP1A2
Hydrochloric Acid SCHEMBL8202584 0.83 MAOB (0.41) NISCHMAOBKDM4EALDH1A1CYP1A2
Hydrochloric Acid SCHEMBL7736789 0.81 NISCH (0.53) NISCHMAOBKDM4EALDH1A1CYP1A2
SCHEMBL8202721 0.80 NISCH (0.47) NISCHMAOBKDM4EALDH1A1CYP1A2
SCHEMBL8194659 0.78 NISCH (0.58) NISCHADRA2AADRA2BADRA2CPDCD1LG2
SCHEMBL6824762 0.78 NISCH (0.58) NISCHMAOBKDM4EALDH1A1CYP1A2
Hydrochloric Acid SCHEMBL7736434 0.77 NISCH (0.57) NISCHMAOBKDM4EALDH1A1CYP1A2
SCHEMBL8187860 0.77 ADRA2A (0.48) NISCHKDM4EADRA2AADRA2BADRA2C
SCHEMBL8199412 0.74 NISCH (0.52) NISCHMAOBKDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000078726-A1 IMIDAZOLINE DERIVATIVES FOR THE TREATMENT OF DIABETES, ESPECIALLY TYPE II DIABETES ELI LILLY AND COMPANY (US) 2000-12-28 — — WO disclosed
Send feedback